US Healthcare Operational Improvements Will Pave Path To Profitability

Published
09 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$8.00
15.3% undervalued intrinsic discount
15 Aug
US$6.78
Loading
1Y
-75.6%
7D
2.7%

Author's Valuation

US$8.0

15.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 75%

Shared on24 Apr 25
Fair value Decreased 48%

AnalystConsensusTarget has decreased future PE multiple from 4.4x to 2.2x.

Shared on17 Apr 25
Fair value Increased 673%

AnalystConsensusTarget has decreased revenue growth from 2.5% to 1.6%, increased future PE multiple from 1.0x to 4.4x, decreased discount rate from 10.2% to 9.0% and increased shares outstanding growth rate from 0.0% to 0.1%.